His primary areas of study are Immunology, Internal medicine, Pathology, Cancer research and Gastroenterology. His Internal medicine study integrates concerns from other disciplines, such as Surgery and Oncology. His biological study spans a wide range of topics, including Cancer, Colorectal cancer, Intestinal mucosa and In vivo.
His Cancer research research is multidisciplinary, incorporating perspectives in Cell growth, Cancer cell, Interleukin 6, Apoptosis and Signal transduction. His Gastroenterology study combines topics from a wide range of disciplines, such as Clinical endpoint, Prospective cohort study, Phases of clinical research and Adenocarcinoma. The study incorporates disciplines such as Proinflammatory cytokine, Molecular biology and Immune system in addition to Cytokine.
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Immunology, Hepatocellular carcinoma and Cancer research. His research integrates issues of Surgery and Oncology in his study of Internal medicine. His study connects Liver transplantation and Gastroenterology.
Many of his studies on Immunology apply to Virology as well. His Hepatocellular carcinoma study incorporates themes from Carcinoma and Ramucirumab. Peter R. Galle focuses mostly in the field of Cancer research, narrowing it down to matters related to Cancer and, in some cases, Pathology.
Internal medicine, Gastroenterology, Hepatocellular carcinoma, In patient and Oncology are his primary areas of study. His study in Ramucirumab, Cirrhosis, Cohort, Fatty liver and Liver disease falls within the category of Internal medicine. His Gastroenterology research incorporates themes from Fibrosis, Prospective cohort study, Liver transplantation and Disease.
His Hepatocellular carcinoma research is multidisciplinary, relying on both Carcinoma, Proportional hazards model and First line treatment. He interconnects Bevacizumab, Open label, Atezolizumab and Biomarker in the investigation of issues within Oncology. The concepts of his Sorafenib study are interwoven with issues in Clinical trial, Progression-free survival and Systemic therapy.
His main research concerns Internal medicine, Hepatocellular carcinoma, In patient, Gastroenterology and Oncology. His research links Resection with Internal medicine. The Hepatocellular carcinoma study combines topics in areas such as Bevacizumab, Carcinoma and First line treatment.
His work in Gastroenterology addresses subjects such as Ramucirumab, which are connected to disciplines such as Hazard ratio, Safety profile and Elevated alpha-fetoprotein. His Oncology research is multidisciplinary, incorporating elements of Open label, Scoring system, Neuroblastoma RAS viral oncogene homolog, Biomarker and Primary tumor. His Pathology research includes themes of Liver injury and Liver function tests.
Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard
Peter R. Galle;Alejandro Forner;Josep M. Llovet;Vincenzo Mazzaferro
Richard S Finn;Shukui Qin;Masafumi Ikeda;Peter R Galle
M. Reig;A. Forner;J. Rimola;J. Ferrer-Fábrega
Elke M. Hennes;Mikio Zeniya;Albert. J. Czaja;Albert Parés
R Atreya;J Mudter;S Finotto;J Müllberg
Andrew X Zhu;Yoon-Koo Kang;Chia-Jui Yen;Richard S Finn
Massimo C. Fantini;Christoph Becker;Giovanni Monteleone;Francesco Pallone
John Bridgewater;Peter R. Galle;Shahid A. Khan;Josep M. Llovet
Ralf Kiesslich;Juergen Burg;Michael Vieth;Janina Gnaendiger
Susanne Strand;Walter J. Hofmann;Hubert Hug;Martina Müller
Martina Müller;Sylvia Wilder;Detlev Bannasch;David Israeli
Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa
Ralf Kiesslich;Johannes Fritsch;Martin Holtmann;Heinz H. Koehler
Imke Tiede;Gerhard Fritz;Susanne Strand;Daniela Poppe
Hartmut Döhner;Konstanze Fischer;Martin Bentz;Katrin Hansen
Peter R. Galle;Walter J. Hofmann;Henning Walczak;Heinz Schaller
Christoph Becker;Massimo C. Fantini;Christoph Schramm;Hans A. Lehr
Martina Müller;Susanne Strand;Hubert Hug;Eva Maria Heinemann
Susetta Finotto;Markus F. Neurath;Jonathan N. Glickman;Shixin Qin
If you think any of the details on this page are incorrect, let us know.
Interested in exploring alternative healthcare careers or supplementing your pre-medical education? Several related online degrees and flexible pathways can help you launch or enhance a career in the health sector.
Nursing is a rewarding option, and students can now find nursing schools that don't require teas or hesi. These programs are ideal for those who wish to avoid standardized entrance exams and start their hands-on medical training more quickly.
If you're interested in leadership roles, consider exploring healthcare administration degrees. These accelerated programs allow you to specialize in management and lead health organizations.
For current registered nurses, there are convenient adn to fnp bridge programs. These pathways enable RNs to advance quickly to a Master’s degree and become Family Nurse Practitioners.
Another growing field is nutrition and wellness. The best online food science degree options equip students for careers in dietetics, food safety, and public health.
These online and accelerated programs provide flexible alternatives for those passionate about healthcare but seeking different or faster career routes outside traditional medical school.
University of Chicago
University of Macau
TU Dresden
Karlsruhe Institute of Technology
University of Birmingham
Northeastern University
Aarhus University
National Institutes of Health
Cardiff University
University of Southampton
University of Konstanz
Eindhoven University of Technology
University College London
Montpellier Business School
University of Lausanne
University of Padua
